Beta-catenin status in pediatric medulloblastomas
收藏官方服务：
资源简介：
Beta-catenin status in pediatric medulloblastomas
应用场景：
创建时间：
2009-02-02
相关数据集
DataSheet_2_Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets.xlsx
As treatment protocols for medulloblastoma (MB) are becoming subgroup-specific, means for reliably distinguishing between its subgroups are a timely need. Currently available methods include immunohis
NIAID Data Ecosystem30
Subgrouping of medulloblastomas based on the evaluation of IHC immunoreactivity for selected protein markers [13].
Subgrouping of medulloblastomas based on the evaluation of IHC immunoreactivity for selected protein markers [13].
Figshare2017-02-24 更新10
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome. Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Medulloblastomas are heterogeneous tumors that collectively represent the most common malignant brain tumor in children. To understand the molecular characteristics underlying their heterogeneity and
NIAID Data Ecosystem10
Table S5 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study
Table S5
NIAID Data Ecosystem20
Single nuclei RNA-seq profiles from medulloblastoma tumors with extensive nodularity [bulk RNA-Seq]
Medulloblastoma with extensive nodularity (MBEN) are cerebellar tumors with two histologically distinct compartments and varying disease course. We invetiagated this tumor class in detail with single
NIAID Data Ecosystem10
